Barinthus Biotherapeutics PLC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Barinthus Biotherapeutics has issued its proxy statement for the 2026 Annual General Meeting to be held on July 2, 2026.
NASDAQ
Barinthus Biotherapeutics PLC announces its 2025 Annual Meeting and provides details on how shareholders can access proxy materials and vote.
NASDAQ
Barinthus Biotherapeutics announces its 2025 Annual General Meeting to be held on June 10, 2025, in London.
NASDAQ
Barinthus Biotherapeutics PLC has filed a definitive proxy statement with the SEC.
NASDAQ
Barinthus Biotherapeutics announces its Annual General Meeting to be held on May 10, 2024, in London, addressing key resolutions including director re-elections and auditor appointments.